Not Verified

Pediatric Alopecia Areata Challenge Grant

National Alopecia Areata Foundation

Alopecia areata (AA) is a common autoimmune skin disease that causes hair loss on the scalp, face, and sometimes on other areas of the body, affecting as many as 160 million people worldwide. Nearly half of patients experience their first episode of alopecia areata before age 20, highlighting the impact of the disease in children and adolescents. Recent clinical data indicate that treatment efficacy decreases with length of time living with severe disease, suggesting that early disease management is needed to prevent a lifetime without hair. Pediatric alopecia areata remains a critical target for research and therapeutic development. Currently, there is only one FDA-approved treatment for adolescents ages 12 and older, limiting effective treatment options for most pediatric patients. The burdens on AA patients and their families are significant, and many key research questions remain unanswered.

To address this need, the National Alopecia Areata Foundation (NAAF) and the Pediatric Dermatology Research Alliance (PeDRA) are collaborating to support research investigations focused on pediatric alopecia areata with the Pediatric Alopecia Areata Challenge Grant. Through this grant, NAAF and PeDRA intend to accelerate research that improves the lives of pediatric alopecia areata patients and their families.

Focus

This Challenge Grant is intended to stimulate scientists to establish or sustain research programs focused on pediatric alopecia areata. Investigators with any innovative research idea are encouraged to apply for the challenge grant, with priority consideration given to proposals that address one or more of the following areas of interest:

Investigations of targets or pathways that will advance understanding of the pathophysiology of pediatric AA
Investigations of epidemiology or the natural history of pediatric AA
Development of patient-reported outcome measures specific to pediatric AA
Elucidation of the burden of pediatric alopecia areata on patients and families, including the psychosocial impact
Advances in treatment or tools for treatment decision-making by patients and families

Priority consideration will be given to projects led by early-to-mid career principal investigators collaborating with senior mentors and projects that address high-priority research questions. Additional priority will be given to applications that support NAAF’s and PeDRA’s commitments to advancing equity, diversity, and inclusion across all facets of their organizations and the research they support.

Important Details
– Up to $75,000 to support one year of research
– One award anticipated for this funding cycle
– Application deadline: Thursday, September 17, 2026
– Awards made: no later than December 12, 2026
– Earliest start date: February 1, 2027

AI Based Application Success Predictor

1. Strong alignment with NAAF research priorities (Highest Predictor ⭐⭐⭐⭐⭐)

This is the most important criterion.

Competitive proposals should directly address one or more NAAF priority areas, including:

Pathophysiology of alopecia areata
Disease mechanisms
New therapeutic targets
Development of animal models
Disease triggers
Biomarker discovery
Patient-reported outcome (PRO) measures
Psychosocial burden of alopecia areata
Comorbid diseases
Treatment decision-support tools
Epidemiology and health services research

Projects aligned with these priority areas receive preferential consideration.

2. Scientific excellence and innovation (Highest Predictor ⭐⭐⭐⭐⭐)

NAAF encourages innovative research across all areas of alopecia areata.

Competitive proposals should demonstrate:

Novel hypotheses
Original scientific concepts
Innovative methodologies
New technologies
Creative approaches to understanding or treating AA

Innovation is emphasized across both Research Grants and Early Career Awards.

3. Potential to improve understanding or treatment of alopecia areata (Highest Predictor ⭐⭐⭐⭐⭐)

Successful proposals should demonstrate potential to:

Improve disease understanding
Advance diagnosis
Develop safer and more effective treatments
Improve treatment decision-making
Enhance quality of life
Contribute toward a future cure

Projects with a clear pathway to patient benefit receive strong consideration.

4. Rigorous methodology and feasibility (Highest Predictor ⭐⭐⭐⭐⭐)

Competitive applications include:

Clearly defined research aims
Robust study design
Appropriate statistical analyses
Realistic timelines
Feasible milestones
Reproducible methods

Applications should demonstrate that the project can be completed successfully within the award period.

5. Focus on high-priority unmet needs (Very High Predictor ⭐⭐⭐⭐⭐)

NAAF gives priority to projects addressing important unmet needs such as:

Disease triggers
Psychosocial burden
Pediatric alopecia areata
Comorbid conditions
Patient-reported outcomes
Novel therapeutic targets
Clinical decision-support tools

Research that addresses these gaps is particularly competitive.

6. Support for early-career investigators (Very High Predictor ⭐⭐⭐⭐⭐)

A defining feature of NAAF is its investment in early-career researchers.

Priority is given to:

Junior investigators
New investigators entering alopecia areata research
Applicants without previous NAAF funding (for Early Career Awards)
Researchers establishing independent AA research programs

The Foundation aims to bring new investigators and ideas into the field.

7. Investigator expertise and research environment (Very High Predictor ⭐⭐⭐⭐⭐)

Reviewers evaluate:

Scientific expertise
Publication record
Research experience
Institutional support
Laboratory or clinical infrastructure
Mentorship (for trainee-focused awards)

A strong research environment increases confidence in project success.

8. Patient-centered research and quality-of-life impact (High Predictor ⭐⭐⭐⭐☆)

NAAF places considerable emphasis on research that addresses:

Patient experiences
Family impact
Quality of life
Psychosocial outcomes
Shared decision-making
Patient-reported outcomes

Projects that incorporate the patient perspective align well with Foundation priorities.

9. Equity, diversity, and inclusion (EDI) and collaboration (High Predictor ⭐⭐⭐⭐☆)

For programs such as the Pediatric Alopecia Areata Challenge Grant, additional consideration is given to:

Projects supporting equity, diversity, and inclusion
Collaborations with senior mentors
Partnerships with pediatric dermatology researchers
Multidisciplinary research teams

These factors can strengthen competitiveness when applicable.

10. Well-prepared application and compliance with funding requirements (High Predictor ⭐⭐⭐⭐☆)

Successful applications include:

Complete documentation
Appropriate budget
Required IRB/IACUC approvals (when applicable)
Compliance with eligibility requirements
Timely submission

Well-organized and compliant applications are more likely to progress successfully through review.

Specialties

Clinical Trials

Public Health

Eligibility Requirements

Applicants need not be trained in pediatric dermatology but must hold the degree of MD and/or PhD (or equivalent) and be eligible to apply for grants under the guidelines of their host institution. Principal Investigators need not be United States citizens and the research need not be conducted in the United States. Evidence of IRB or IACUC (or equivalent) approval is required for all studies when relevant. Recipients of past or current NAAF and/or PeDRA grants are eligible to apply.

Sponsor Details

Sponsor Institute/Organizations: National Alopecia Areata Foundation

Sponsor Type: Corporate/Non-Profit

Address: 1500 Grant Ave Suite 242 Novato, CA 94945

Legal & Affiliation Disclaimer

Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.

Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.

Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.

Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.

Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.

Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.

Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.

View Funding Opportunity